RePORT International What’s New

The “WHO operational handbook on tuberculosis. Module 3: diagnosis” provides an implementation guidance on detection of TB infection, disease and drug resistance within a single reference document. It also provides updates to the diagnostic algorithms, in view of new recommendations on concurrent testing of respiratory and non-respiratory samples among adults and adolescents with HIV, children with HIV, and children without HIV or with unknown HIV status. Finally, it summarizes updates on diagnostic accuracy of the WHO recommended technologies, in view of the WHO TB Diagnostic guidelines updates as well as analysis of discordant results. This document accompanies the “WHO consolidated guidelines on tuberculosis. Module 3: diagnosis”, which summarizes and updates the latest WHO recommendations on the detection of TB infection, disease, and drug resistance for Member States, technical partners, and other stakeholders.

The new WHO TPPs for TB screening tests were developed after an extensive consultation of a large cross section of constituencies. They provide manufacturers and other stakeholders in research and development with the latest product- and technology-agnostic guidance that encompass all possible approaches used for TB screening.

Application deadline: 20 November 2025 This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing. Please refer to the website for details

8-12 September 2025 | 7:30-11:00am PT Virtual format | Registration open The University of Washington Advanced TB Research Training Course will cover diverse topic in TB research, including the current understanding of TB pathophysiology, diagnostics, therapeutics and prevention, immunology and vaccine development, transmission dynamics, implementation science, and disease modeling. In addition, the course will cover special topics, including TB maternal and child health and people living with HIV. Participants will develop knowledge and skills in both theory and methods for advancing TB research. Participants will learn from case studies, lectures, panel discussions, and interactions with attendees and faculty. Finally, participants will engage in active learning opportunities to develop a hierarchical priority list and research plan to help advance tuberculosis research. Course Sponsors: Bill & Melinda Gates Foundation, University of Washington Tuberculosis Research and Training Center.

To address the need for trustworthy and scientifically based information focused on providing a basic understanding of science, HANC responded by creating an ad-hoc work group with international membership to develop videos on several important topics. On this page you will find videos and links to additional resources that aim to make understanding science and clinical research easier. Videos include: Why is Science Essential?, Why is Research Important in Science?, Who are Clinical Research Stakeholders?, The Scientific Method, and Regulations and Clinical Research Studies.

Deadline: 10 September 2025 This scheme is for outstanding scientists who are in the early stages of their research career and have the potential to become leaders in their field. These long-term fellowships provide the opportunity and freedom to build an independent research career in the UK or Republic of Ireland and pursue cutting-edge scientific research. The fellowship covers following research areas: Ai: Astronomy, cosmology, physics, earth sciences, environmental physical sciences & geosciences Aii: Chemistry and engineering Aiii: Pure and applied mathematics, computer science, statistics, communications and computer engineering; the mathematical aspects of astronomy, physics, cosmology, gravitation, theoretical physics Bi: Molecular and cellular biology, zoology, plant sciences and physiology Bii: Biomedical Sciences  

The Antibacterial Resistance Leadership Group (ARLG) invites requests for industry collaboration from the ARLG in the form of advice, guidance, protocol design for drug, device, or diagnostic development. The ARLG develops, designs, implements, and manages a clinical research agenda to increase knowledge of antibacterial resistance (AR). The ARLG aims to advance research by building transformational trials that will change clinical practice and reduce the impact of antibacterial resistance and antimicrobial resistance through the following strategies: - Early clinical evaluation of new antibacterials; - Comparative effectiveness or efficacy trials; - Strategy trials to optimize currently licensed antibacterials (dose, duration, need for drug) to reduce the risk of resistance; - Clinical algorithm testing strategies; - Treatment-based prevention measures; - Diagnostics testing in the context of treatment trials, epidemiologic elements, or behavioral modification; - Effective infection control programs which include surveillance for resistant organisms, outbreak investigation, and antibiotic stewardship to prevent the development and spread of resistant organisms; - Novel facilities level activities to prevent the development of resistance.

The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs. Despite this progress, 2.7 million individuals with TB still remain undiagnosed and undetected. On July 17th, 2025, TAG hosted a community webinar on tests for TB and drug resistance. The webinar breaks down the latest WHO guidelines and explores the most effective tools for diagnosing TB and drug resistance. The webinar also launched TAG’s updated resource, An Activist’s Guide to Diagnostic Tools for Tuberculosis, and provides a deep dive into two sections of the Guide: (1) the array of WHO-recommended diagnostic tools and how they should be optimally used in country programs; and (2) key access considerations and actions activists can take to ensure that all people at risk of TB receive quality TB diagnostic testing.

Application Deadline: 30 September 2025 The Foundation is seeking highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field. All applications must be approved by the University Provost or the Vice President of Research, and should be submitted through the office of sponsored research or like office that provides institutional approval for the request. Studies selected through an internal competition are preferred. Applications submitted by an individual researcher will NOT be considered." Please refer to the link below for more specific information on this RFP.

Closing date: 22 September 2025 The main objectives of this funding instrument are to: Support promising clinicians who want to obtain doctoral qualifications while retaining their employment or clinical duties. Assist institutions in developing innovative and effective dual-training pathways, which provide the opportunity for PhD-level research alongside the conventional clinical training track. The award is designed to offer flexible and realistic options to clinicians who want to pursue their PhD studies. It may be used to provide protected research time from clinical training or clinical service obligations to support PhD studies undertaken in parallel with clinical activities. The use of funds is strictly for research training, i.e., obtaining a PhD. SAMRC priority research areas: Biomedical Research HIV, TB and other communicable diseases Health System Strengthening Health Promotion and Disease Prevention Maternal, child and woman health Non-communicable diseases Public Health Innovation Violence, injury and trauma